Last reviewed · How we verify

NCT03525535: MAXIME

Prevalence Rate of Pulmonary Embolism Among Not Anticoagulated Patients

Terminated Last updated 16 September 2019
What this trial tests

trial testing data collection in Pulmonary Embolism in 1 participant. Terminated before completion.

Timeline
14 June 2018
Primary endpoint
27 November 2018
27 November 2018

Quick facts

Lead sponsorCentre Hospitalier Intercommunal de Toulon La Seyne sur Mer
StatusTerminated
Study typeOBSERVATIONAL
Enrollment1
Start date14 June 2018
Primary completion27 November 2018
Estimated completion27 November 2018
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer

Who can join

75 and older, any sex, with Pulmonary Embolism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate the prevalence rate of pulmonary embolism among not anticoagulated patient older than 75 years old admitted with syncope and hospitalised in the Toulon Hospital

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of data collection

Trials testing the same drug.

Other recruiting trials for Pulmonary Embolism

Currently open trials in the same condition.

Other Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03525535.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing